Vials of the Pfizer/BioNtech coronavirus disease (COVID-19) vaccine are displayed before being used at a mobile vaccine clinic in Valparaiso, Chile, on January 3, 2022. Rodrigo Garrido | Reuters shares of BioNTech on Monday slipped more than 6% in morning trade after the German drugmaker shared a gloomy 2023 sales outlook for its jointly developed …
Continue reading “BioNTech shares slide on bleak Covid vaccine gross sales outlook”